Sourcing novel classes of drugs from the one of the largest biodiversity hotspot on the planet

Axonova is a pioneer drug discovery platform in Mauritius exploring and valorizing the Southern African biodiversity. Axonova focuses on the development of natural compounds and botanical drugs targeting signaling pathways relevant to CNS disorders.

The company operates under a hybrid business model. Next to advancing its own pipeline of innovative drug candidates, the company offers services related to discovery and development of pharmaceuticals and nutraceuticals in the field of neuroscience.